Clinical Trials : Hemophilia B

Completed

Study Name: Study Evaluating rFIX; BeneFIX in Severe Hemophilia B
Condition: Hemophilia B
Date: 2002-05-17
Interventions: Drug: BeneFIX

Completed

Study Name: Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual Use
Condition: Hemophilia B
Date: 2005-09-11

Completed

Study Name: Phase I/IIa Study of FIXFc in Hemophilia B Patients
Condition: Hemophilia B
Date: 2008-07-14
Interventions: Drug: rFIXFc As specified in the treatment arm Other

Completed

Study Name: Study Evaluating BENEFIX in Previously Treated Patients With Hemophilia B
Condition: Hemophilia B
Date: 2007-12-21
Interventions: Drug: Recombinant Factor IX Coagulation Benefix IV each 12 hours for 2 a 5 days

Active, not recruiting

Study Name: Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B
Condition: Hemophilia B
Date: 2015-03-04
Interventions: Genetic: AAV5-hFIX AAV5hFIX gene therapy Other Name:

Completed

Study Name: Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B
Condition: Hemophilia B
Date: 2006-08-14
Interventions:

Drug: Recombinant Coagulation Factor IX (BeneFIX)

Active, not recruiting

Study Name: Safety and Dose Finding Study of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B
Condition: Hemophilia B
Date: 2015-11-23
Interventions: Genetic: AAVrh10FIX non-replicating recombinant AAVrh10 encoding human FIX (hFIX)

Recruiting

Study Name: Long-Term Safety, Tolerability, and Efficacy of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B
Condition: Hemophilia B
Date: 2016-11-21

Active, not recruiting

Study Name: Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B
Condition: Hemophilia B
Date: 2011-01-06
Interventions: Drug: Recombinant factor IX Product, IB1001 On-Demand or Prophylaxis

Completed

Study Name: Efficacy and Safety of AlphaNine Versus BeneFIX in Patients With Severe Hereditary Haemophilia B
Condition: Hemophilia B
Date: 2017-03-16
Interventions: Drug: BeneFIX BeneFIX is a recombinant FIX that contains nonacog alfa, reconstituted in solvent and admi

Search for Clinical Trial Results

Hemophilia B - 25 Studies Found

Status	Study
Completed	Study Name: Study Evaluating rFIX; BeneFIX in Severe Hemophilia B Condition: Hemophilia B Date: 2002-05-17 Interventions: Drug: BeneFIX
Completed	Study Name: Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual Use Condition: Hemophilia B Date: 2005-09-11
Completed	Study Name: Phase I/IIa Study of FIXFc in Hemophilia B Patients Condition: Hemophilia B Date: 2008-07-14 Interventions: Drug: rFIXFc As specified in the treatment arm Other
Completed	Study Name: Study Evaluating BENEFIX in Previously Treated Patients With Hemophilia B Condition: Hemophilia B Date: 2007-12-21 Interventions: Drug: Recombinant Factor IX Coagulation Benefix IV each 12 hours for 2 a 5 days
Active, not recruiting	Study Name: Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B Condition: Hemophilia B Date: 2015-03-04 Interventions: Genetic: AAV5-hFIX AAV5hFIX gene therapy Other Name:
Completed	Study Name: Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B Condition: Hemophilia B Date: 2006-08-14 Interventions: Drug: Recombinant Coagulation Factor IX (BeneFIX)
Active, not recruiting	Study Name: Safety and Dose Finding Study of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B Condition: Hemophilia B Date: 2015-11-23 Interventions: Genetic: AAVrh10FIX non-replicating recombinant AAVrh10 encoding human FIX (hFIX)
Recruiting	Study Name: Long-Term Safety, Tolerability, and Efficacy of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B Condition: Hemophilia B Date: 2016-11-21
Active, not recruiting	Study Name: Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B Condition: Hemophilia B Date: 2011-01-06 Interventions: Drug: Recombinant factor IX Product, IB1001 On-Demand or Prophylaxis
Completed	Study Name: Efficacy and Safety of AlphaNine Versus BeneFIX in Patients With Severe Hereditary Haemophilia B Condition: Hemophilia B Date: 2017-03-16 Interventions: Drug: BeneFIX BeneFIX is a recombinant FIX that contains nonacog alfa, reconstituted in solvent and admi